Standardizing the immunological measurement of advanced glycation endproducts using normal human serum

Journal of Immunological Methods

Volumn 207, Issue 1, 1997, Pages 79-88

  Mitsuhashi, Tomoko ^a   Vlassara, Helen ^a   Founds, H W ^b   Li, Yong Ming ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b Alteon Inc   (United States)

Author keywords

Advanced glycation endproducts; Diabetic complications; ELISA; Glycation; Normal human serum

Indexed keywords

GLYCOSYLATED PROTEIN;

ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; SERUM; STANDARDIZATION;

ADULT; AGED; AGING; ANTIBODIES; ANTIBODY SPECIFICITY; CARRIER PROTEINS; CROSS REACTIONS; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LABORATORIES; MALE; NORMAL DISTRIBUTION;

EID: 0030755308     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(97)00110-5     Document Type: Article

References (17)

1. Ahmed M.U., Thorpe S.R., Baynes J.W. Identification of carboxymethyllysine as a degradation product of fructosyllysine in glycated protein. J. Biol. Chem. 261:1986;4889.
2. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405.
3. Brennan M. Changes in solubility, non-enzymatic glycation, and fluorescence of collagen in tail tendons from diabetic rats. J. Biol. Chem. 260:1989;20947.
4. Farmar J., Ulrich P.C., Cerami A. Novel pyrroles from sulfite-inhibited Mailard reactions: Insight into the mechanism of inhibition. J. Org. Chem. 53:1988;2346.
5. Harlow, E., Lane, D., 1988. A Laboratory Manual. Cold Spring Harbor Laboratory, New York, p. 139.
6. Horiuchi S., Araki N., Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J. Biol. Chem. 266:1991;7329.
7. Li Y.M., Tan A.X., Vlassara H. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nature Med. 1:1995;1057.
8. Macdonald R.A., Hosking C.S., Jones C.L. The measurement of relative antibody affinity by ELISA using thiocyanate elution. J. Immunol. Methods. 106:1988;191.
9. Makita Z., Vlassara H., Cerami A., Bucara R. Immunochemical detection of advanced glycosylation end products. J. Biol. Chem. 267:1992;5133.
10. Mitsuhashi T., Nakayama H., Itoh T., Kuwajima S., Aoki S., Atsumi T., Koike T. Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat. Diabetes. 42:1993;826.
11. Nakamura K., Hasegawa T., Fukunaga Y., Lenaga K. Crosslines A and B as candidate for the fluorophores in age- and diabetes-related cross-linked proteins, and their diacetates produced by Maillard reaction of a-N-Acetyl-L-lysine with D-Glucose. J. Chem. Soc. Chem. Commun. 14:1992;992.
12. Nakayama H., Taneda S., Kuwajima S., Aoki S., Kuroda Y., Misawa K., Nakagawa S. Production and characterization of antibodies to advanced glycosylation products on proteins. Biochem. Biophys. Res. Commun. 162:1989;740.
13. Njoroge F.G., Fernandes A.A., Monnier V.M. 3-(D-erythrotrihydroxy-propyl)-1-neopentyl pyrrole-2-carboxyaldehyde, a novel nonenzymatic browning product of glucose. J. Carbohydr. Chem. 6:1987;553.
14. Papanastasiou P., Cirass L., Rodela H., Patrikarea A., Oreopoulos D., Diamandis E.P. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int. 46:1994;216.
15. Pongor S., Ulrich P.C., Bencsath F.A., Cerami A. Aging of proteins: Isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc Natl. Acad. Sci. USA. 81:1984;2684.
16. Sell D.R., Monnier V.M. Structure elucidation of senescence crosslink from human extracellular matrix: Implication of pentoses in the aging process. J. Biol. Chem. 264:1989;21597.
17. Vlassara H., Bucala R., Strike L. Biology of disease. Pathogenic effects of advanced glycation: Biochemical, biologic, and clinical implication for diabetes and aging. Lab. Invest. 70:1994;138.